https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and
29 Aug 2019
// John Carroll ENDPTS
https://endpts.com/fda-fires-off-a-warning-on-rare-cases-involving-death-adverse-liver-events-linked-to-misuse-of-3-big-hep-c-drugs/
28 Aug 2019
// Jacob Bell BIOPHARMADIVE
https://www.biopharmadive.com/news/fda-safety-warning-hepatitis-c-drugs-patient-deaths/561891/
10 Apr 2019
// John LaMattina FORBES
https://www.forbes.com/sites/johnlamattina/2019/04/10/the-biopharmaceutical-cartel-and-high-drug-prices/#4fb4c4e6533c
07 Feb 2019
// Mark Miller REUTERS
https://www.reuters.com/article/us-column-miller-medicare/medicare-part-d-no-match-for-runaway-specialty-drug-costs-study-idUSKCN1PW16X
04 Oct 2018
// Eric Palmer FIERCE PHARMA
https://www.fiercepharma.com/manufacturing/merck-runs-out-parkinson-s-disease-drug-sinemet-as-manufacturing-issues-unexpected